DOAJ Open Access 2022

S224: PRELIMINARY RESULTS OF A PHASE II STUDY OF ORELABRUTINIB IN COMBINATION WITH ANTI-PD-1 MONOCLONAL ANTIBODY IN REFRACTORY OR RELAPSED PRIMARY CNS LYMPHOMA

Y. Zhang W. Wang D. Zhao Y. Zhang W. Zhang +1 lainnya

Penulis (6)

Y

Y. Zhang

W

W. Wang

D

D. Zhao

Y

Y. Zhang

W

W. Zhang

D

D. Zhou

Format Sitasi

Zhang, Y., Wang, W., Zhao, D., Zhang, Y., Zhang, W., Zhou, D. (2022). S224: PRELIMINARY RESULTS OF A PHASE II STUDY OF ORELABRUTINIB IN COMBINATION WITH ANTI-PD-1 MONOCLONAL ANTIBODY IN REFRACTORY OR RELAPSED PRIMARY CNS LYMPHOMA. https://doi.org/10.1097/01.HS9.0000843788.10370.07

Akses Cepat

Informasi Jurnal
Tahun Terbit
2022
Sumber Database
DOAJ
DOI
10.1097/01.HS9.0000843788.10370.07
Akses
Open Access ✓